These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28066877)

  • 21. Comparative evaluation of positron emission tomography radiotracers for imaging the norepinephrine transporter: (S,S) and (R,R) enantiomers of reboxetine analogs ([11C]methylreboxetine, 3-Cl-[11C]methylreboxetine and [18F]fluororeboxetine), (R)-[11C]nisoxetine, [11C]oxaprotiline and [11C]lortalamine.
    Ding YS; Lin KS; Logan J; Benveniste H; Carter P
    J Neurochem; 2005 Jul; 94(2):337-51. PubMed ID: 15998285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The central nervous norepinephrine network links a diminished sense of emotional well-being to an increased body weight.
    Melasch J; Rullmann M; Hilbert A; Luthardt J; Becker GA; Patt M; Villringer A; Arelin K; Meyer PM; Lobsien D; Ding YS; Müller K; Sabri O; Hesse S; Pleger B
    Int J Obes (Lond); 2016 May; 40(5):779-87. PubMed ID: 26620766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central Serotonin/Noradrenaline Transporter Availability and Treatment Success in Patients with Obesity.
    Griebsch NI; Kern J; Hansen J; Rullmann M; Luthardt J; Helfmeyer S; Dekorsy FJ; Soeder M; Hankir MK; Zientek F; Becker GA; Patt M; Meyer PM; Dietrich A; Blüher M; Ding YS; Hilbert A; Sabri O; Hesse S
    Brain Sci; 2022 Oct; 12(11):. PubMed ID: 36358364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a new norepinephrine transporter PET ligand in baboons, both in brain and peripheral organs.
    Ding YS; Lin KS; Garza V; Carter P; Alexoff D; Logan J; Shea C; Xu Y; King P
    Synapse; 2003 Dec; 50(4):345-52. PubMed ID: 14556239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative analysis of norepinephrine transporter in the human brain using PET with (S,S)-18F-FMeNER-D2.
    Arakawa R; Okumura M; Ito H; Seki C; Takahashi H; Takano H; Nakao R; Suzuki K; Okubo Y; Halldin C; Suhara T
    J Nucl Med; 2008 Aug; 49(8):1270-6. PubMed ID: 18632811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of Dopamine D1 Receptor and Noradrenaline Transporter in Individuals with Autism Spectrum Disorder: A PET Study.
    Kubota M; Fujino J; Tei S; Takahata K; Matsuoka K; Tagai K; Sano Y; Yamamoto Y; Shimada H; Takado Y; Seki C; Itahashi T; Aoki YY; Ohta H; Hashimoto RI; Zhang MR; Suhara T; Nakamura M; Takahashi H; Kato N; Higuchi M
    Cereb Cortex; 2020 Nov; 30(12):6458-6468. PubMed ID: 32770189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ¹²³I-NKJ64: a novel single photon emission computed tomography radiotracer for imaging the noradrenaline transporter in brain.
    Tavares AA; Jobson NK; Dewar D; Sutherland A; Pimlott SL
    Synapse; 2011 Jul; 65(7):658-67. PubMed ID: 21157929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The norepinephrine transporter (NET) radioligand (S,S)-[18F]FMeNER-D2 shows significant decreases in NET density in the human brain in Alzheimer's disease: a post-mortem autoradiographic study.
    Gulyás B; Brockschnieder D; Nag S; Pavlova E; Kása P; Beliczai Z; Légrádi A; Gulya K; Thiele A; Dyrks T; Halldin C
    Neurochem Int; 2010; 56(6-7):789-98. PubMed ID: 20211213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased brainstem and putamen SERT binding potential in depressed suicide attempters using [11C]-zient PET imaging.
    Nye JA; Purselle D; Plisson C; Voll RJ; Stehouwer JS; Votaw JR; Kilts CD; Goodman MM; Nemeroff CB
    Depress Anxiety; 2013 Oct; 30(10):902-7. PubMed ID: 23526784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No correlation between body mass index and striatal dopamine transporter availability in healthy volunteers using SPECT and [123I]PE2I.
    Thomsen G; Ziebell M; Jensen PS; da Cuhna-Bang S; Knudsen GM; Pinborg LH
    Obesity (Silver Spring); 2013 Sep; 21(9):1803-6. PubMed ID: 23696269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mapping of the norepinephrine transporter in the human brain using PET with (S,S)-[18F]FMeNER-D2.
    Takano A; Varrone A; Gulyás B; Karlsson P; Tauscher J; Halldin C
    Neuroimage; 2008 Aug; 42(2):474-82. PubMed ID: 18617423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iodine-123 labeled reboxetine analogues for imaging of noradrenaline transporter in brain using single photon emission computed tomography.
    Tavares AA; Jobson NK; Dewar D; Sutherland A; Pimlott SL; Batis J; Barret O; Seibyl J; Tamagnan G
    Synapse; 2012 Nov; 66(11):923-30. PubMed ID: 22807144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensory experience of food and obesity: a positron emission tomography study of the brain regions affected by tasting a liquid meal after a prolonged fast.
    DelParigi A; Chen K; Salbe AD; Reiman EM; Tataranni PA
    Neuroimage; 2005 Jan; 24(2):436-43. PubMed ID: 15627585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
    Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
    J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [11C]NS8880, a promising PET radiotracer targeting the norepinephrine transporter.
    Vase KH; Peters D; Nielsen EØ; Alstrup AK; Bender D
    Nucl Med Biol; 2014 Oct; 41(9):758-64. PubMed ID: 25127515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant mesolimbic dopamine-opiate interaction in obesity.
    Tuominen L; Tuulari J; Karlsson H; Hirvonen J; Helin S; Salminen P; Parkkola R; Hietala J; Nuutila P; Nummenmaa L
    Neuroimage; 2015 Nov; 122():80-6. PubMed ID: 26260431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Norepinephrine transporter occupancy by nortriptyline in patients with depression: a positron emission tomography study with (S,S)-[¹⁸F]FMeNER-D₂.
    Takano H; Arakawa R; Nogami T; Suzuki M; Nagashima T; Fujiwara H; Kimura Y; Kodaka F; Takahata K; Shimada H; Murakami Y; Tateno A; Yamada M; Ito H; Kawamura K; Zhang MR; Takahashi H; Kato M; Okubo Y; Suhara T
    Int J Neuropsychopharmacol; 2014 Apr; 17(4):553-60. PubMed ID: 24345533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and synthesis of (2R,3S)-iodoreboxetine analogues for SPECT imaging of the noradrenaline transporter.
    Jobson NK; Crawford AR; Dewar D; Pimlott SL; Sutherland A
    Bioorg Med Chem Lett; 2009 Sep; 19(17):4996-8. PubMed ID: 19640707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral serotonin transporter binding is inversely related to body mass index.
    Erritzoe D; Frokjaer VG; Haahr MT; Kalbitzer J; Svarer C; Holst KK; Hansen DL; Jernigan TL; Lehel S; Knudsen GM
    Neuroimage; 2010 Aug; 52(1):284-9. PubMed ID: 20382236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2.
    Seneca N; Gulyás B; Varrone A; Schou M; Airaksinen A; Tauscher J; Vandenhende F; Kielbasa W; Farde L; Innis RB; Halldin C
    Psychopharmacology (Berl); 2006 Sep; 188(1):119-27. PubMed ID: 16896954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.